CONFIRMED ATTENDING COMPANIES INCLUDE:
A. Menarini I.F.R.
AAIPharma Services Corp. | Cambridge Major Laboratories, Inc.
AbbVie, Inc.
Abzena PLC
Addex Therapeutics Ltd.
adivo
Affas Besse Advisors Ltd.
AGLAIA BioMedical Ventures B.V.
Akaal Pharma Pty Ltd.
Akinion Pharmaceuticals AB
Alexion Pharma International
Almirall
ALSTIN
Alzheimer's Research UK
Amadix
Amcure
Amorchem
AM-Pharma B.V.
Anteo Diagnostics Ltd
APIM Therapeutics AS
Aravis SA
Arcus Ventures
AstraZeneca
Athera Biotechnologies AB
Atriva Therapeutics GmbH
Aurgalys
Aurum Holdings MKI Ltd.
Austin Life Science Partners AG
Avexxin AS
B3C Group
Bay City Capital LLC
BB Biotech Ventures
Beechwood Ventures
Bellevue Asset Management AG
Bellicum Pharmaceuticals, Inc.
Belmont Capital
Belsize Asset Management
BerGenBio AS
Berlin Partner for Business and Technology GmbH
Bicycle Therapeutics Limited
BioBac BioValley Business Angels Club
BioLife Solutions, Inc
BioLineRx
BioMedPartners AG
BioPharm Insight
BioSight Ltd.
BioStart Consulting GmbH
Biotech Finances
Bio-Technopark, Schlieren-Zurich
BioValley Basel & Suterscience, LLC
Bird & Bird LLP
Boehringer Ingelheim GmbH Venture Fund
Boehringer Ingelheim Pharma GmbH & Co. KG
Bootstrap Europe
Brean Capital, LLC
Breslin AG
Brock Capital Group LLC
Calypso Biotech SA
Canbex Therapeutics Ltd.
Capricorn One
Cell Therapy Ltd.
Cellestia Biotech AG
Cellply s.r.l.
ChinaBio Capital
Colpman Consulting Ltd.
COMPLIX nv
ContraVir Pharmaceuticals, Inc.
Corinthian Financial Management Ltd.
Coulter Partners
Cukierman & Co. Life Sciences
Curetis N.V.
DC4U BV
Debiopharm Diagnostics SA
Deca Ventures
Drooms
Eckert Life Science Accelerator GmbH (ELSA)
Economic and Trade Department, Embassy of Israel
Edison
Edmond de Rothschild Investment Partners
Eli Lilly & Co.
EMD Serono
EMTensor GmbH
Enso Ventures
Eos Biosciences, Inc.
Ernst & Young AG
ETH Zurich
EVA - the Basel life sciences start-up agency
F. Hoffmann-La Roche, Diagnostics Division
Forbion Capital Partners
Fountain Healthcare Partners
Fraser Finance
FreeMind Group
Fukoku Life International (UK) Ltd.
fundamenta CAPITAL AG
GeneCode Ltd.
Genetics Microdevices Ltd.
Gilde Healthcare
GIMV
GlaxoSmithKline
Glide Pharmaceutical Technologies Limited
GLOBAL CARE Initiative
Global Life Science Ventures
goetzpartners holding
Grabulovski Consulting Services
GreenBone Ortho srl
HBM Partners AG
HCB Healthcubator GmbH
Health Advances GmbH
HealthCare Royalty Partners
Helsinn Healthcare SA
Helvea Baader Bank
High Beacon Ltd.
High-Tech Gruenderfonds Management GmbH
IBM
ICF (Switz.)
IMI Consulting GmbH
ImmunID
Imperial Innovations
Industrifonden
Inflamalps SA
InGeneron, Inc.
INKEF Capital BV
Innovation In Medtech, LLC
InnVentis Ltd.
Inofea AG
Inositec
Inserm Transfert Initiative
INSTITUT DE RECHERCHE PIERRE FABRE
Institute for Chemical and Bioengineering
InSymbiosis Capital
Inthera Bioscience AG
inVentiv Health, Inc.
Inventiva Pharma
Inveready
IPSA
ISA Pharmaceuticals B.V.
Italian Angels for Growth
Johnson & Johnson Innovation
Johnson & Johnson Innovation - JJDC, Inc.
Johnson and Johnson
Joint Polish Investment Fund
Kamfarma
Karus Therapeutics Ltd
KOTRA Zurich
Kreos Capital
Labiotech
Lanthio Pharma B.V., A MorphoSys Company
Leo Consulting
LeukoDx Ltd.
LifeCare Partners
LifeSci Advisors
Luc Therapeutics, Inc.
MainFirst
Marinomed Biotechnologie GmbH
MC Services AG
MD1 Management Direct AG
Mediatum Schweiz GmbH
Medicxi Ventures
Medimetrics Personalized Medicine
MedLumics S.L.
MedPro Investors, LLC
MedVenture Partners GmbH
Merchant Liquidity Fund, LP
Merck KGaA
Mergermarket
Merieux Developpement
Metellus AG
MISSION Therapeutics Ltd.
MPM Capital
MS Ventures
MSD
MTIP MedTech Innovation Partners AG
Mymetics Corporation
MyoPowers Medical Technologies France SAS
Nasdaq
Navamedic ASA
Neomed
Nextech Invest Ltd.
Norgine Ventures
NOVA SATRA HEALTH Sdn. Bhd.
Novartis AG
Novartis Pharma AG
Novartis Venture Fund
Novasecta Ltd.
Novo Nordisk A/S
Novo Seeds
Novo Ventures
Numab AG
OCT
Omega Funds
Oppenheimer & Co., Inc.
OSE Pharma
Oxford BioMedica Ltd.
Oxford BioTherapeutics AG
Oxyrane Group
Peppermint Venture Partners GmbH
Pfizer, Inc.
Pharmanest AB
PharmaVentures Ltd.
Pierre Fabre Fund for Innovation
Pierre Fabre Medicament, SA
Pitango Venture Capital
PlasmaMedic Ltd
PM Equity Partner
Porterhouse Group AG
PRAGMA Therapeutics
Predemtec GmbH
Prexton Therapeutics
Prima Biomed Gmbh (BF)
Primer Capital
ProAxsis Ltd.
Pronec Ltd.
Provectus Biopharmaceuticals, Inc.
Provista Diagnostics, Inc.
PsiOxus Therapeutics Ltd
QIAGEN GmbH
RBV Capital
Redalpine Venture Partners
Retired
RMI Partners
Roche DC EMEA
Roche Venture Fund
Rockport Venture Partners
Rodman & Renshaw, LLC
Rosetta Capital Ltd
Royal Bank of Canada
RSA AG
S.R.One, Limited
Sachs Associates Ltd.
Salus Partners
Sanofi
SciCoTec GmbH
SCRIP Intelligence
seiratherm GmbH
Seroba Life Sciences
Seventure Partners
Silence Therapeutics PLC
Sirius Healthcare Partners
SIX Swiss Exchange
Skolkovo Foundation
SMR Consulting GmbH
SNS Securities
Sofinnova Partners
Sophia Genetics
Stanphyl Capital
STEPSTONE Pharma
Stratos Bio
Stratpharma AG
Strekin AG
Sunergos Innovations
Sunstone Capital A/S
Sunstone Life Science Ventures
SV Life Sciences
TaiwanJ Pharmaceuticals
Takeda Pharmaceuticals International GmbH
Takeda Ventures, Inc.
Targovax ASA
Teva Pharmaceutical Industries Ltd.
The Alpine Institute for Drug Discovery
The Fulford Group
The Trout Group
Therabron Therapeutics
Therametrics
TheraVenture GmbH
Thuja Capital B.V.
Tissue Regenix Group plc
Torreya Partners (Europe), LLP
Transparency Life Sciences
Triskel Biopharmaceuticals AG
TVM Capital China Limited
TVM Life Science Management Inc.
TxCell
UCB Pharma
Umblin AG
Umecrine Cognition AB
UP Biotech Management AG
valuationLAB AG
Vaxart, Inc.
Vaximm
Vectron Biosolutions AS
Ventac Partners
Vernalis plc
Versantis AG
VI Partners AG
Virometix AG
Visium Asset Management
Vogel BioC
Waypoint Capital
Wellcome Trust
Wellington Partners
Wingspan Ventures
WuXi AppTec, Inc.
Xeltis
XOventure GmbH
Yorkville Advisors, LLC
Ysios Capital Partners
Zukunftsfonds Heilbronn GmbH & Co KG
Zytoprotec GmbH
A. Menarini I.F.R.
AAIPharma Services Corp. | Cambridge Major Laboratories, Inc.
AbbVie, Inc.
Abzena PLC
Addex Therapeutics Ltd.
adivo
Affas Besse Advisors Ltd.
AGLAIA BioMedical Ventures B.V.
Akaal Pharma Pty Ltd.
Akinion Pharmaceuticals AB
Alexion Pharma International
Almirall
ALSTIN
Alzheimer's Research UK
Amadix
Amcure
Amorchem
AM-Pharma B.V.
Anteo Diagnostics Ltd
APIM Therapeutics AS
Aravis SA
Arcus Ventures
AstraZeneca
Athera Biotechnologies AB
Atriva Therapeutics GmbH
Aurgalys
Aurum Holdings MKI Ltd.
Austin Life Science Partners AG
Avexxin AS
B3C Group
Bay City Capital LLC
BB Biotech Ventures
Beechwood Ventures
Bellevue Asset Management AG
Bellicum Pharmaceuticals, Inc.
Belmont Capital
Belsize Asset Management
BerGenBio AS
Berlin Partner for Business and Technology GmbH
Bicycle Therapeutics Limited
BioBac BioValley Business Angels Club
BioLife Solutions, Inc
BioLineRx
BioMedPartners AG
BioPharm Insight
BioSight Ltd.
BioStart Consulting GmbH
Biotech Finances
Bio-Technopark, Schlieren-Zurich
BioValley Basel & Suterscience, LLC
Bird & Bird LLP
Boehringer Ingelheim GmbH Venture Fund
Boehringer Ingelheim Pharma GmbH & Co. KG
Bootstrap Europe
Brean Capital, LLC
Breslin AG
Brock Capital Group LLC
Calypso Biotech SA
Canbex Therapeutics Ltd.
Capricorn One
Cell Therapy Ltd.
Cellestia Biotech AG
Cellply s.r.l.
ChinaBio Capital
Colpman Consulting Ltd.
COMPLIX nv
ContraVir Pharmaceuticals, Inc.
Corinthian Financial Management Ltd.
Coulter Partners
Cukierman & Co. Life Sciences
Curetis N.V.
DC4U BV
Debiopharm Diagnostics SA
Deca Ventures
Drooms
Eckert Life Science Accelerator GmbH (ELSA)
Economic and Trade Department, Embassy of Israel
Edison
Edmond de Rothschild Investment Partners
Eli Lilly & Co.
EMD Serono
EMTensor GmbH
Enso Ventures
Eos Biosciences, Inc.
Ernst & Young AG
ETH Zurich
EVA - the Basel life sciences start-up agency
F. Hoffmann-La Roche, Diagnostics Division
Forbion Capital Partners
Fountain Healthcare Partners
Fraser Finance
FreeMind Group
Fukoku Life International (UK) Ltd.
fundamenta CAPITAL AG
GeneCode Ltd.
Genetics Microdevices Ltd.
Gilde Healthcare
GIMV
GlaxoSmithKline
Glide Pharmaceutical Technologies Limited
GLOBAL CARE Initiative
Global Life Science Ventures
goetzpartners holding
Grabulovski Consulting Services
GreenBone Ortho srl
HBM Partners AG
HCB Healthcubator GmbH
Health Advances GmbH
HealthCare Royalty Partners
Helsinn Healthcare SA
Helvea Baader Bank
High Beacon Ltd.
High-Tech Gruenderfonds Management GmbH
IBM
ICF (Switz.)
IMI Consulting GmbH
ImmunID
Imperial Innovations
Industrifonden
Inflamalps SA
InGeneron, Inc.
INKEF Capital BV
Innovation In Medtech, LLC
InnVentis Ltd.
Inofea AG
Inositec
Inserm Transfert Initiative
INSTITUT DE RECHERCHE PIERRE FABRE
Institute for Chemical and Bioengineering
InSymbiosis Capital
Inthera Bioscience AG
inVentiv Health, Inc.
Inventiva Pharma
Inveready
IPSA
ISA Pharmaceuticals B.V.
Italian Angels for Growth
Johnson & Johnson Innovation
Johnson & Johnson Innovation - JJDC, Inc.
Johnson and Johnson
Joint Polish Investment Fund
Kamfarma
Karus Therapeutics Ltd
KOTRA Zurich
Kreos Capital
Labiotech
Lanthio Pharma B.V., A MorphoSys Company
Leo Consulting
LeukoDx Ltd.
LifeCare Partners
LifeSci Advisors
Luc Therapeutics, Inc.
MainFirst
Marinomed Biotechnologie GmbH
MC Services AG
MD1 Management Direct AG
Mediatum Schweiz GmbH
Medicxi Ventures
Medimetrics Personalized Medicine
MedLumics S.L.
MedPro Investors, LLC
MedVenture Partners GmbH
Merchant Liquidity Fund, LP
Merck KGaA
Mergermarket
Merieux Developpement
Metellus AG
MISSION Therapeutics Ltd.
MPM Capital
MS Ventures
MSD
MTIP MedTech Innovation Partners AG
Mymetics Corporation
MyoPowers Medical Technologies France SAS
Nasdaq
Navamedic ASA
Neomed
Nextech Invest Ltd.
Norgine Ventures
NOVA SATRA HEALTH Sdn. Bhd.
Novartis AG
Novartis Pharma AG
Novartis Venture Fund
Novasecta Ltd.
Novo Nordisk A/S
Novo Seeds
Novo Ventures
Numab AG
OCT
Omega Funds
Oppenheimer & Co., Inc.
OSE Pharma
Oxford BioMedica Ltd.
Oxford BioTherapeutics AG
Oxyrane Group
Peppermint Venture Partners GmbH
Pfizer, Inc.
Pharmanest AB
PharmaVentures Ltd.
Pierre Fabre Fund for Innovation
Pierre Fabre Medicament, SA
Pitango Venture Capital
PlasmaMedic Ltd
PM Equity Partner
Porterhouse Group AG
PRAGMA Therapeutics
Predemtec GmbH
Prexton Therapeutics
Prima Biomed Gmbh (BF)
Primer Capital
ProAxsis Ltd.
Pronec Ltd.
Provectus Biopharmaceuticals, Inc.
Provista Diagnostics, Inc.
PsiOxus Therapeutics Ltd
QIAGEN GmbH
RBV Capital
Redalpine Venture Partners
Retired
RMI Partners
Roche DC EMEA
Roche Venture Fund
Rockport Venture Partners
Rodman & Renshaw, LLC
Rosetta Capital Ltd
Royal Bank of Canada
RSA AG
S.R.One, Limited
Sachs Associates Ltd.
Salus Partners
Sanofi
SciCoTec GmbH
SCRIP Intelligence
seiratherm GmbH
Seroba Life Sciences
Seventure Partners
Silence Therapeutics PLC
Sirius Healthcare Partners
SIX Swiss Exchange
Skolkovo Foundation
SMR Consulting GmbH
SNS Securities
Sofinnova Partners
Sophia Genetics
Stanphyl Capital
STEPSTONE Pharma
Stratos Bio
Stratpharma AG
Strekin AG
Sunergos Innovations
Sunstone Capital A/S
Sunstone Life Science Ventures
SV Life Sciences
TaiwanJ Pharmaceuticals
Takeda Pharmaceuticals International GmbH
Takeda Ventures, Inc.
Targovax ASA
Teva Pharmaceutical Industries Ltd.
The Alpine Institute for Drug Discovery
The Fulford Group
The Trout Group
Therabron Therapeutics
Therametrics
TheraVenture GmbH
Thuja Capital B.V.
Tissue Regenix Group plc
Torreya Partners (Europe), LLP
Transparency Life Sciences
Triskel Biopharmaceuticals AG
TVM Capital China Limited
TVM Life Science Management Inc.
TxCell
UCB Pharma
Umblin AG
Umecrine Cognition AB
UP Biotech Management AG
valuationLAB AG
Vaxart, Inc.
Vaximm
Vectron Biosolutions AS
Ventac Partners
Vernalis plc
Versantis AG
VI Partners AG
Virometix AG
Visium Asset Management
Vogel BioC
Waypoint Capital
Wellcome Trust
Wellington Partners
Wingspan Ventures
WuXi AppTec, Inc.
Xeltis
XOventure GmbH
Yorkville Advisors, LLC
Ysios Capital Partners
Zukunftsfonds Heilbronn GmbH & Co KG
Zytoprotec GmbH